The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 801–900 of 1,072
Biased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: An overview
Martin, F., Sánchez-Hernández, S., Gutiérrez-Guerrero, A., Pinedo-Gomez, J., & Benabdellah, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091507 · Cited by 92
Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering
Nuñez, J. K., Harrington, L. B., & Doudna, J. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01019 · Cited by 92
Self-citationWaking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system
Garcia-Bloj, B., Moses, C., Sgro, A., Plani-Lam, J., Arooj, M., Duffy, C., Thiruvengadam, S., Sorolla, A., Rashwan, R., Mancera, R. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11142 · Cited by 91
“pyogenes), which has helicase activity and two nuclease sites [33].”
BackgroundCan CRISPR-Based Gene Drive Be Confined in the Wild? A Question for Molecular and Population Biology
Marshall, J. M., & Akbari, O. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00923 · Cited by 92
Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency
Hiranniramol, K., Chen, Y., Liu, W., & Wang, X. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa041 · Cited by 89
“The CRISPR/CRISPR-associated protein 9 (Cas9) system belongs to Class 2 systems and is the most widely used editing system due to its simplicity, high efficiency and low cost (Doudna and Charpentier, 2014).”
BackgroundEfficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies
Nüssing, S., House, I. G., Kearney, C. J., Chen, A. X. Y., Vervoort, S. J., Beavis, P. A., Oliaro, J., Johnstone, R. W., Trapani, J. A., & Parish, I. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901396 · Cited by 103
Small animal PET: a review of what we have done and where we are going
Miyaoka, R. S., & Lehnert, A. L. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab8f71 · Cited by 92
Beyond safety: mapping the ethical debate on heritable genome editing interventions
Almeida, M., & Ranisch, R. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01147-y · Cited by 103
Rahman, S. U., McCoy, E., Raza, G., Ali, Z., Mansoor, S., & Amin, I. U. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00456-6 · Cited by 106
Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery
Mollé, L. M., Smyth, C. H., Yuen, D., & Johnston, A. P. R. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1809 · Cited by 100
“CRISPR gene editing systems require at least two components: CRISPR endonuclease Cas9 and an RNA guide strand (gRNA) to target the Cas9 component to the correct position in the DNA (O'Driscoll & Jeggo, 2006).”
BackgroundMethodInfluentialFei, H., Li, Y., Liu, Y., Wei, J., Chen, A. A., & Gao, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.014 · Cited by 105
Wernet, M. F., Perry, M. W., & Desplan, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.04.006 · Cited by 89
Singh, V., Gohil, N., Ramirez-Garcia, R., Braddick, D., & Fofié, C. K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26165 · Cited by 97
“KEY WORDS: CRISPR-Cas9; sgRNA; DSB; NHEJ; HDR; INDELS; THERAPEUTIC Recent advances in genome editing technologies have led to newrevolutions and innovations in biological and biomedical research [Doudna and Charpentier, 2014; Hsu et al., 2014; Cox et al., 2015; Riordan et al., 2015].”
BackgroundGiant liposome formation toward the synthesis of well-defined artificial cells
Kamiya, K., & Takeuchi, S. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01322a · Cited by 101
Efficient gene editing in Corynebacterium glutamicum using the CRISPR/Cas9 system
Peng, F., Wang, X., Sun, Y., Dong, G., Yang, Y., Liu, X., & Bai, Z. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0814-6 · Cited by 98
Cas9, Cpf1 and C2c1/2/3―What's next?
Nakade, S., Yamamoto, T., & Sakuma, T. (2017) · Bioengineered · doi:10.1080/21655979.2017.1282018 · Cited by 90
“The CRISPR-Cas9 system has various advantages over the past engineered nucleases such as zinc-finger nucleases and transcription activator-like effector nucleases.(6) First, the vector construction becomes quite simple.”
BackgroundCRISPR-Based Typing and Next-Generation Tracking Technologies
Barrangou, R., & Dudley, E. G. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-022814-015729 · Cited by 101
Novel mutagenesis and screening technologies for food microorganisms: advances and prospects
Yu, Q., Li, Y., Wu, B., Hu, W., He, M., & Hu, G. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10341-z · Cited by 95
“Genome-editing technology using the CRISPR system is a recent powerful tool (Doudna and Charpentier 2014; Hsu et al. 2014).”
Engineering biosynthetic enzymes for industrial natural product synthesis
Galanie, S. S., Entwistle, D. A., & Lalonde, J. J. (2020) · Natural Product Reports · doi:10.1039/c9np00071b · Cited by 93
Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions
Tiwari, A. K., Krisnawati, D. I., Susilowati, E., Mutalik, C., & Kuo, T. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08702 · Cited by 95
The therapeutic application of CRISPR/Cas9 technologies for HIV
Saayman, S. M., Ali, S. A., Morris, K. V., & Weinberg, M. S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1036736 · Cited by 107
“This results in deletions generated by non-homologous end joining (NHEJ) at the binding site, or in homologous-dependent repair (HDR) (reviewed in [79]).”
BackgroundImmunoliposomes for cancer therapy.
Kontermann, R. E. (2006) · PubMed · Cited by 117
Synthetic Lethality and Cancer – Penetrance as the Major Barrier
Ryan, C. J., Bajrami, I., & Lord, C. J. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.08.003 · Cited by 94
An integrated protocol for targeted mutagenesis with CRISPR-Cas9 system in the pea aphid
Trionnaire, G. L., Tanguy, S., Hudaverdian, S., Gléonnec, F., Richard, G., Cayrol, B., Monsion, B., Pichon, E., Deshoux, M., Webster, C., et al. (2019) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2019.04.016 · Cited by 98
“This system relies on the use of a single-guide RNA 91 (sgRNA) and a Cas9 nuclease (Doudna and Charpentier, 2014).”
MethodWang, X., Liu, D., He, D., Suo, S., Xia, X., He, X., Han, J. J., & Zheng, P. (2017) · Genome Research · doi:10.1101/gr.198044.115 · Cited by 104
“However, current protocols for genome editing by homologous recombination (HR) – mediated DNA replacement in monkey one-cell embryos are extremely inefficient (Doudna and Charpentier 2014).”
Improvement of phytochemical production by plant cells and organ culture and by genetic engineering
Nielsen, E., Temporiti, M. E. E., & Cella, R. (2019) · Plant Cell Reports · doi:10.1007/s00299-019-02415-z · Cited by 97
Kim, H. J., Ogura, S., Otabe, T., Kamegawa, R., Sato, M., Kataoka, K., & Miyata, K. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00843 · Cited by 97
“Also, the optimized derivative, PAsp(DET/CHE 11 ) 26 , was demonstrated to have a high potential for the IVT mRNA-mediated genome engineering.”
InfluentialAttaining the promise of plant gene editing at scale
Nasti, R. A., & Voytas, D. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004846117 · Cited by 88
Simon, A. J., d’Oelsnitz, S., & Ellington, A. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0157-4 · Cited by 96
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Awwad, S. W., Serrano-Benítez, A., Thomas, J. C., Gupta, V., & Jackson, S. P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00571-x · Cited by 101
Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis
Ngo, H. K. C., Kim, D.-H., Cha, Y.-N., Na, H.-K., & Surh, Y.-J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3538 · Cited by 87
“A recently developed ready-to-used genome editing technology CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats/ CRISPR-associated protein 9) may offer a new therapeutic approach for intervention of liver cancer caused by ‘gain-of-function’ mutations in Nrf2 (44-46).”
MethodWang, Y., Liu, K. I., Sutrisnoh, N.-A. B., Srinivasan, H., Zhang, J., Li, J., Zhang, F., Lalith, C. R. J., Xing, H., Shanmugam, R., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1445-x · Cited by 86
“Distinct endogenous DNA repair pathways are harnessed to achieve desired genome engineering outcomes [12, 13].”
BackgroundQuantitative Analysis of Synthetic Cell Lineage Tracing Using Nuclease Barcoding
Schmidt, S. T., Zimmerman, S. M., Wang, J., Kim, S. K., & Quake, S. R. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00309 · Cited by 90
Genome sequencing in the clinic: the past, present, and future of genomic medicine
Prokop, J. W., May, T., Strong, K. A., Bilinovich, S. M., Bupp, C. P., Rajasekaran, S., Worthey, E. A., & Lazar, J. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00046.2018 · Cited by 94
Cas9 Cleavage of Viral Genomes Primes the Acquisition of New Immunological Memories
Nussenzweig, P. M., McGinn, J., & Marraffini, L. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.09.002 · Cited by 93
“Finally, the wide use of Cas9 as a tool for genome engineering of the human genome (Doudna and Charpentier, 2014) has revealed the existence of ‘‘off-target’’ sites.”
BackgroundCorte, L. E.-D., Mahmoud, L. M., Moraes, T. D. S., Mou, Z., Grosser, J. W., & Dutt, M. (2019) · Plants · doi:10.3390/plants8120601 · Cited by 102
““scaffold” sequence necessary for Cas9 binding [13,36].”
BackgroundThe “IAG-Switch”—A Key Controlling Element in Decapod Crustacean Sex Differentiation
Levy, T., & Sagi, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00651 · Cited by 89
Gupta, A., Hua, L., Zhang, Z., Yang, B., & Li, W. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13969 · Cited by 90
Deep learning in CRISPR-Cas systems: a review of recent studies
Lee, M. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1226182 · Cited by 99
“The epoch of genomic engineering has been decidedly invigorated by the advent of the CRISPR-Cas9 system, an innovative tool that has dramatically transformed the landscape of genetic modi fi cation (Doudna and Charpentier, 2014).”
BackgroundMethodThingujam, D., Gouli, S., Cooray, S. P., Chandran, K. B., Givens, S., Renganathan, V. G., Tan, Z., Wang, Y., Patam, K., Greer, S. A., et al. (2025) · Plants · doi:10.3390/plants14172699 · Cited by 110
“CRISPR-Cas9 technology has revolutionized plant genetic engineering by enabling precise, efficient, and targeted modifications of plant genomes, providing a transformative platform for improving stress tolerance traits [107].”
Kolli, N., Lü, M., Maiti, P., Rossignol, J., & Dunbar, G. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040754 · Cited by 99
“The CRISPR-Cas 9 system is now broadly applied to eukaryotes for editing genes, including creating knock-in, knock-out, and also to correct the mutated genes in the genome [15].”
BackgroundIn silico structure-based approaches to discover protein-protein interaction-targeting drugs
Shin, W.-H., Christoffer, C. W., & Kihara, D. (2017) · Methods · doi:10.1016/j.ymeth.2017.08.006 · Cited by 82
Yuen, G., Khan, F. J., Gao, S., Stommel, J. M., Batchelor, E., Wu, X., & Luo, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx843 · Cited by 94
“Cas9 is an RNA-dependent DNA endonuclease that utilizes a single guide RNA (sgRNA) to introduce doublestranded DNA breaks (4).”
BackgroundCas9-assisted recombineering in C. elegans : genome editing using in vivo assembly of linear DNAs
Paix, A., Schmidt, H., & Seydoux, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw502 · Cited by 88
“CRISPR–Cas9 technology has simplified methods to introduce exogenous DNA into eukaryotic genomes (5).”
Genome editing and plant transformation of solanaceous food crops
Eck, J. M. V. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.07.012 · Cited by 90
Tobler, M., Kelley, J. L., Plath, M. W., & Riesch, R. (2018) · Molecular Ecology · doi:10.1111/mec.14497 · Cited by 92
“While gene editing with CRISPR–Cas9 is now routinely employed in model organisms (Doudna & Charpentier, 2014; Shalem, Sanjana, & Zhang, 2015), applying this technology to nonmodels still remains challenging, especially in livebearing species like poeciliid fishes where in vitro culture of embryos…”
MethodDronina, J., Samukaitė-Bubnienė, U., & Ramanavičius, A. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112867 · Cited by 89
A DNA Origami‐Based Gene Editing System for Efficient Gene Therapy in Vivo
Tang, W., Tong, T., Wang, H., Lu, X., Yang, C., Wu, Y., Wang, Y., Liu, J., & Ding, B. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202315093 · Cited by 93
Precise genome-editing in human diseases: mechanisms, strategies and applications
Zheng, Y., Li, Y., Zhou, K., Li, T., VanDusen, N. J., & Hua, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01750-2 · Cited by 106
Bacterial CRISPR: accomplishments and prospects
Peters, J. M., Silvis, M. R., Zhao, D., Hawkins, J. S., Gross, C. A., & Qi, L. S. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.08.007 · Cited by 96
Using CRISPR/Cas in three dimensions: towards synthetic plant genomes, transcriptomes and epigenomes
Puchta, H. (2016) · The Plant Journal · doi:10.1111/tpj.13100 · Cited by 86
Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System
Qazi, S., Miettinen, H. M., Wilkinson, R. A., McCoy, K., Douglas, T., & Wiedenheft, B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00822 · Cited by 85
Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides
Ding, X., Seebeck, T., Feng, Y., Jiang, Y., Davis, G. D., & Chen, F. (2019) · The CRISPR Journal · doi:10.1089/crispr.2018.0036 · Cited by 84
“The bacterial-derived CRISPR-Cas9 nucleases have emerged in recent years as a widely adopted tool in genome editing, 1,2 greatly accelerating and expanding the genome engineering field created with previous programmable nucleases, such as ZFNs and TALENs.”
Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
Silva, M. C., & Haggarty, S. J. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14012 · Cited by 83
Recent advances in enhancement of oil content in oilseed crops
Zafar, S., Li, Y., Li, N., Zhu, K., & Tan, X. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.05.307 · Cited by 87
Skryabin, B. V., Kummerfeld, D.-M., Gubar, L., Seeger, B., Kaiser, H., Stegemann, A., Roth, J., Meuth, S. G., Pavenstädt, H., Sherwood, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax2941 · Cited by 89
“The crRNA contains ~20 nt of recognition sequence complementary to the targeting region of DNA, whereas tracrRNA interacts with Cas9 protein and base pairs with crRNA (8).”
BackgroundProgress and Perspectives in the Development of Lentiviral Vector Producer Cells
Ferreira, M. V., Cabral, E. T., & Coroadinha, A. S. (2020) · Biotechnology Journal · doi:10.1002/biot.202000017 · Cited by 93
Shin, J. J., Schröder, M., Caiado, F., Wyman, S. K., Bray, N., Bordi, M., DeWitt, M. A., Vu, J. T., Kim, W., Hockemeyer, D. F., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108093 · Cited by 95
“CRISPR-Cas genome editing has emerged as a powerful tool that enables fundamental research into genotype-phenotype relationships and holds great promise for the treatment of genetic disease (Doudna and Charpentier, 2014; Fellmann et al., 2017; Sternberg and Doudna, 2015).”
BackgroundModular genetic control of social status in a cichlid fish
Alward, B. A., Laud, V. A., Skalnik, C. J., York, R. A., Juntti, S. A., & Fernald, R. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008925117 · Cited by 91
Zhang, X., Jin, H., Huang, X., Chaurasiya, B., Dong, D., Shanley, T. P., & Zhao, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110196 · Cited by 93
Evolutionary plasticity and functional versatility of CRISPR systems
Koonin, E. V., & Makarova, K. S. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001481 · Cited by 92
Kang, Y., Su, G., Yu, Y., Cao, J., Wang, J., & Yan, B. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c06733 · Cited by 88
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Azeez, S. S., Hamad, R. S., Hamad, B., Shekha, M. S., & Bergsten, P. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1509924 · Cited by 107
Insect Resistance to Insecticides: Causes, Mechanisms, and Exploring Potential Solutions
Liang, J., Xiao, F., Ojo, J. A., Chao, W. H., Ahmad, B., Alam, A., Abbas, S., Abdelhafez, M. M., Rahman, N., Khan, K. A., et al. (2025) · Archives of Insect Biochemistry and Physiology · doi:10.1002/arch.70045 · Cited by 99
Controlled activation of retrotransposition for plant breeding
Paszkowski, J. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.01.003 · Cited by 110
Katoh, Y., Michisaka, S., Nozaki, S., Funabashi, T., Hirano, T., Takei, R., & Nakayama, K. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-01-0051 · Cited by 88
“INTRODUCTION The development of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) technology has revolutionized genome editing in virtually all organisms (Doudna and Charpentier, 2014; Hsu et al., 2014).”
Zheng, Y., Lin, F.-L., Gao, H., Zou, G., Zhang, J.-W., Wang, G., Chen, G., Zhou, Z., Yao, X., & Hu, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-10052-3 · Cited by 92
Port, F., Muschalik, N., & Bullock, S. L. (2015) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.115.019083 · Cited by 87
“…Drosophila CRISPR mutagenesis homologydirected repair gene drive The Clustered Regularly Interspaced Short Palindromic Repeat/ CRISPR associated (CRISPR/Cas) genome engineering system is currently revolutionizing experimental and applied biology (Hsu et al. 2014; Doudna and Charpentier 2014).”
BackgroundChu, U. B., Mavlyutov, T. A., Chu, M.-L., Yang, H., Schulman, A., Mesangeau, C., McCurdy, C. R., Guo, L.-W., & Ruoho, A. E. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.017 · Cited by 86
“Application of this new genome-editing technology is rapidly expanding because of its effectiveness in completely depleting an endogenous protein (Doudna and Charpentier, 2014), especially in contrast to siRNA knockdown, which is able to reduce a targeted protein typically by 50–60%.”
BackgroundFocused Review: Cytotoxic and Antioxidant Potentials of Mangrove-Derived Streptomyces
Ser, H., Tan, L. T., Law, J. W., Chan, K., Duangjai, A., Saokaew, S., Pusparajah, P., Mutalib, N. A., Khan, T. M., Goh, B. H., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02065 · Cited by 87
“The CRISPR-Cas9 system -a powerful genome editing techniqueis mainly used to delete or knock-out genes (Cobb et al., 2014; Doudna and Charpentier, 2014).”
BackgroundGenomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
Knight, S. C., Tjian, R., & Doudna, J. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201709201 · Cited by 85
Self-citationA New Zealand Perspective on the Application and Regulation of Gene Editing
Fritsche, S., Poovaiah, C. R., MacRae, E., & Thorlby, G. J. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01323 · Cited by 91
“Alfalfa CRISPR/Cas9 Agrobacterium- mediated transformation of leaf disks Mutate squamosa promoter binding protein like 9 (SPL9) gene First generation plants regenerated Gao et al., 2018”
MethodInfluentialEngineering of lactic acid bacteria for delivery of therapeutic proteins and peptides
Plavec, T. V., & Berlec, A. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09628-y · Cited by 94
Liu, Q., He, D., & Xie, L. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007480 · Cited by 81
Genome editing on finfish: Current status and implications for sustainability
Blix, T., Dalmo, R. A., Wargelius, A., & Myhr, A. I. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12571 · Cited by 88
“We also saw that a majority (26) of the studies (56) state utilization in aquaculture is the main objective of their research.”
BackgroundEvolutionary genetics of the mitochondrial genome: insights from Drosophila
Dowling, D. K., & Wolff, J. N. (2023) · Genetics · doi:10.1093/genetics/iyad036 · Cited by 98
Soltanmohammadi, F., Gharehbaba, A. M., Zangi, A. R., Adibkia, K., & Javadzadeh, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117248 · Cited by 95
Linossi, E. M., & Nicholson, S. E. (2015) · Immunological Reviews · doi:10.1111/imr.12305 · Cited by 83
Effective screen of CRISPR/Cas9-induced mutants in rice by single-strand conformation polymorphism
Zheng, X., Yang, S., Zhang, D., Zhong, Z., Tang, X. D., Deng, K., Zhou, J., Qi, Y., & Zhang, Y. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1967-1 · Cited by 89
“Streptococcus pyogenes Cas9 (SpCas9) is prevalently used in genome editing applications presumably due its wellcharacterized PAM motif (NGG) (Doudna and Charpentier 2014; Hsu et al. 2014; Sander and Joung 2014).”
BackgroundPPR-SMR protein SOT1 has RNA endonuclease activity
Zhou, W., Lu, Q., Li, Q., Wang, L., Ding, S., Zhang, A., Wen, X., Zhang, L., & Lu, C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612460114 · Cited by 98
“Recently, the CRISPR/Cas9 system has been widely used in the field of genome editing (53, 54).”
MethodAdvanced domestication: harnessing the precision of gene editing in crop breeding
Lyzenga, W. J., Pozniak, C. J., & Kagale, S. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13576 · Cited by 85
Li, Y., Yang, T., Yu, Y., Shi, N., Yang, L., Glass, Z., Bolinger, J., Finkel, I. J., Li, W., & Xu, Q. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.011 · Cited by 84
Mutagenesis of seed storage protein genes in Soybean using CRISPR/Cas9
Li, C., Nguyen, V., Liu, J., Fu, W., Chen, C., Yu, K., & Cui, Y. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4207-2 · Cited by 96
“The CRISPR/Cas9 system has emerged as a robust technology for efficient genome editing [10, 11], and has been successfully applied in many major crops, including soybean [12–16].”
Xiang, X., Qian, K., Zhang, Z., Lin, F., Xie, Y., Liu, Y., & Yang, Z. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1769637 · Cited by 95
Gupta, S., Kumar, A., Patel, R., & Kumar, V. S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06477-9 · Cited by 94
“Also, the CRISPR-Cas9 system has been experimentally validated for deletion or insertion with precise targeting [4] .”
MethodCombining speed breeding with traditional and genomics‐assisted breeding for crop improvement
Pandey, S., Singh, A. K., Parida, S. K., & Prasad, M. (2022) · Plant Breeding · doi:10.1111/pbr.13012 · Cited by 99
CRISPR/Cas9 Technology and Its Utility for Crop Improvement
Liu, H., Chen, W., Li, Y., Sun, L., Chai, Y., Chen, H., Nie, H., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810442 · Cited by 92
CRISPR genome engineering and viral gene delivery: A case of mutual attraction
Schmidt, F., & Grimm, D. (2015) · Biotechnology Journal · doi:10.1002/biot.201400529 · Cited by 84
Guernet, A. A., Mungamuri, S. K., Cartier, D., Sachidanandam, R., Jayaprakash, A. D., Adriouch, S., Vézain, M., Charbonnier, F., Rohkin, G., Coutant, S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.017 · Cited by 89
“We designed specific sgRNA constructs and two donor DNAs for APC HDR, containing either the repaired (APC-WT) or a STOP codon, as well as a two series of silent mutations to serve as specific barcodes (Figure S4B).”
BackgroundInfluentialDNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA
Zheng, Y., Lorenzo, C., & Beal, P. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx050 · Cited by 83
Genome editing in crop improvement: Present scenario and future prospects
Miglani, G. S. (2017) · Journal of Crop Improvement · doi:10.1080/15427528.2017.1333192 · Cited by 84
Non-homologous DNA increases gene disruption efficiency by altering DNA repair outcomes
Richardson, C. D., Ray, G. J., Bray, N. L., & Corn, J. E. (2016) · Nature Communications · doi:10.1038/ncomms12463 · Cited by 80
Efficient Genome Editing in Caenorhabditis elegans with a Toolkit of Dual-Marker Selection Cassettes
Norris, A. D., Kim, H., Colaiácovo, M. P., & Calarco, J. A. (2015) · Genetics · doi:10.1534/genetics.115.180679 · Cited by 92
“…CRISPR-associated endonuclease, Cas9, have been used to generate custom mutations, indels, and transgene insertions in a wide variety of organisms (Doudna and Charpentier 2014), including Caenorhabditis elegans (Chen et al. 2013; Chiu et al. 2013; Cho et al. 2013; Dickinson et al. 2013; Friedland…”
BackgroundThe Growing Development of DNA Nanostructures for Potential Healthcare‐Related Applications
Mathur, D., & Medintz, I. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801546 · Cited by 96
Applications of CRISPR-Cas9 as an Advanced Genome Editing System in Life Sciences
Tavakoli, K., Pour‐Aboughadareh, A., Kianersi, F., Poczai, P., Etminan, A., & Shooshtari, L. (2021) · BioTech · doi:10.3390/biotech10030014 · Cited by 94
Habimana, J. D. D., Huang, R., Muhoza, B., Kalisa, N. Y., Han, X. B., Deng, W., & Li, Z. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114033 · Cited by 94
Wang, Y., Wang, X., Xie, R., Burger, J. C., Tong, Y., & Gong, S. (2022) · Advanced Materials · doi:10.1002/adma.202208018 · Cited by 95
CRISPR-Cas: A robust technology for enhancing consumer-preferred commercial traits in crops
Verma, V., Kumar, A., Partap, M., Thakur, M., & Bhargava, B. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1122940 · Cited by 96
“CRISPR-Cas9, a novel and incredibly useful family of SSNs, has been used to edit and regulate both DNA and RNA, enabling precise engineering of the plant genome (Hsu et al., 2013; Doudna and Charpentier, 2014; Zaidi et al., 2016; Aman et al., 2018; Mahas and Mahfouz, 2018; Bruetschy, 2019; Eid et al., 2021).”
BackgroundKalebic, N., Taverna, E., Tavano, S., Wong, F. K., Suchold, D., Winkler, S., Huttner, W. Β., & Sarov, M. (2016) · EMBO Reports · doi:10.15252/embr.201541715 · Cited by 89
Phage Genetic Engineering Using CRISPR–Cas Systems
Hatoum-Aslan, A. (2018) · Viruses · doi:10.3390/v10060335 · Cited by 78
“Among the most simple of the CRISPR–Cas systems [54], Type II (also known as CRISPR–Cas9) are, thus far, the most commonly used for genome editing applications [19].”
Background
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.